Cambridge Investment Research Advisors Inc. Sells 1,650 Shares of iShares Biotechnology ETF (NASDAQ:IBB)
Cambridge Investment Research Advisors Inc. trimmed its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 2.4% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 67,580 shares of the financial services provider’s stock after selling 1,650 shares during the period. Cambridge Investment Research […]
Cambridge Investment Research Advisors Inc. trimmed its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 2.4% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 67,580 shares of the financial services provider’s stock after selling 1,650 shares during the period. Cambridge Investment Research […]
